Sources | Names Used |
---|---|
CTRPv2 | JQ-1:navitoclax (2:1 mol/mol) |
PharmacoGx | JQ-1:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SBNO2 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | MMADHC | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0006 |
mRNA | RDX | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | PSD | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0006 |
mRNA | CYB5D1 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
mRNA | SSFA2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0006 |
mRNA | ZDHHC22 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | KARS | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0007 |
mRNA | EDA | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
mRNA | ZNF724 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |